Skip to content
healthcare.dev

ATENOLOL AND CHLORTHALIDONE

NDC 10135-734, atenolol and chlorthalidone tablet, tablet, from MARLEX PHARMACEUTICALS, INC.

Product NDC
10135-734
Status
Listed
Labeler
MARLEX PHARMACEUTICALS, INC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215560
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-734 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATENOLOL100 mg/1
  • CHLORTHALIDONE25 mg/1

Pharmacologic classes

Adrenergic beta-Antagonists [MoA]; Increased Diuresis [PE]; Thiazide-like Diuretic [EPC]; beta-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
10135-734-0110135073401100 TABLET in 1 BOTTLE (10135-734-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/db22ff31-52f6-9024-e053-2995a90af8b3

Use it

Look up 10135-734 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-734 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-734. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.